Approval · Notice of Compliance 18318 · 2016
TARO-TESTOSTERONE: Notice of Compliance 18318
Issued July 27, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18318
- Date
- July 27, 2016
- Company
- Taro Pharmaceuticals IncBrampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- New labels for the bottles of 50 and 100 capsules
- Canadian reference product
- ANDRIOL (Merck Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TARO-TESTOSTERONE | Not yet assigned | — |
Medicinal ingredients
- TESTOSTERONE UNDECANOATE 40 MG per CAP